Ohr Pharmaceutical Inc 4
4 · Ohr Pharmaceutical Inc · Filed May 24, 2016
Insider Transaction Report
Form 4
Backenroth Samuel
CEO & VP of Bus. Development
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.23/sh+163$526→ 136,362 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.21/sh+184$591→ 136,557 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.18/sh+192$611→ 136,955 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.16/sh+379$1,198→ 138,168 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.11/sh+33$103→ 138,699 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.22/sh+11$35→ 136,373 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.19/sh+152$485→ 136,763 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.17/sh+834$2,644→ 137,789 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.15/sh+184$580→ 138,352 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.13/sh+11$34→ 138,503 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.13/sh+97$304→ 138,492 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.12/sh+163$509→ 138,666 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.20/sh+54$173→ 136,611 total - Purchase
Common Stock, par value $0.0001 per share
2016-05-23$3.14/sh+43$135→ 138,395 total